Campaign Life Coalition

Overseas Abortion Drug Kills Woman in Secret, At-Home Abortion in Canada A 31-year-old woman from Alberta is dead, along with her baby, after using an abortion drug sourced overseas in a secretive, off-label abortion. The woman, whose name cannot be published due to a court-ordered ban, learned she was pregnant in January 2024. Due to lack of medical coverage, family expectations, and community optics, court documents state, the woman decided to pursue an abortion. She was given $500 by her partner for the abortion and ordered "unknown medication" from the Philippines. By the time she consumed it on June 10, 2024, she was at least 5 months pregnant, well past Canada's nine-week cutoff line for a Mifegymiso-induced chemical abortion. She began to experience abdominal pain. Over the next several days, the woman's physical health worsened. She and her partner nevertheless continued to hide her pregnancy and abortion plan from family and health care providers. They convinced her family that she was simply experiencing stomach aches, diarrhea, and vertigo. Four days into the abortion procedure, the woman gave birth to the baby in a pool of blood on the bathroom floor, court documents indicate. It is unclear if the baby was delivered alive or had died previously. Whatever the case, she hid the body. The woman was then unable to get up from the floor. Even at this point, the couple tried to keep what they had done a secret from the woman's family, who were trying to care for her. By that evening, the woman was unresponsive. A neighbour who was also a nurse called 911. Paramedics arrived before the woman went into cardiac arrest. They performed CPR on her before transporting her to the hospital. The woman never recovered. On July 4, approximately three weeks after inducing the abortion, the woman died at a long-term care facility. The woman's partner was accused of failing to report the body of the child to the police, making him a party to an offence of concealing the body of a child contrary to the Criminal Code. This is the second woman in Canada in four years whose death has been publicly linked to abortion drugs. 19-year-old Rheanna Laderoute from Ontario died in 2022 after taking the abortion drug Mifegymiso. She died of “septic shock,” a known risk of chemical abortion pills. Canadian abortion activists have hailed these drugs as the “gold standard” for ending the life of a preborn child. Health Canada’s adverse-reaction database, however, contains more than one hundred reports of serious harm to Canadian women since the regimen became available in 2017. The product monograph published on Health Canada’s website for the mifepristone/misoprostol combination explicitly warns of risks of serious harm and death. Listed risks include heavy bleeding that may require transfusion and infections that can progress to fatal septic shock. The tragic stories of these two women highlight just how unsafe abortion drug protocols can be to women. Together, the two deaths illustrate that serious complications can arise, both when abortion drugs are used under Canadian regulations and when they are used off-label. What is most responsible for these tragic deaths is a culture that treats preborn human lives as disposable and presents chemical abortion as a straightforward, low-risk solution. Women accordingly view the deliberate ending of a pregnancy as an ordinary medical choice rather than one that carries real risks of hemorrhage, infection, and death. Women deserve better. The truth is that abortion drugs are not safe. They are not safe for women, and they are certainly not safe for preborn babies. The documented risks of heavy bleeding, infection, and septic shock, together with the deaths of multiple women in Canada and innumerable preborn babies, make a strong case for a moratorium on abortion drugs. Photo/Shutterstock

Canadian group linked to US woman jailed after live birth following abortion pills A U.S. woman is behind bars after obtaining abortion pills with the help of a Canadian-based organization and using them in an attempt to abort her baby in the second trimester—well beyond the pills’ recommended gestational limit. The baby, a boy, came out alive, but then died after the woman left him on a closet shelf. On December 21, 2025, Margaret Conant from Iowa obtained abortion pills with the help of Women on Web, a Canadian non-profit organization that describes itself as “facilitating online access to abortion pills.” The pills require a prescription in Iowa, a process that Conant decided to bypass because she was already some 26 weeks pregnant—far beyond the cut-off date of roughly 10 weeks that the abortion pill stipulates. Conant reached out to Women on Web and lied about her baby’s gestational age to obtain the pills. She took the abortion pills and delivered a living baby boy who was making sounds and “barely breathing,” according to the criminal complaint. Instead of calling for emergency help, Conant wrapped her newborn baby in a towel, put him into a bag, and placed him on a shelf in the closet—leaving him for dead. Two days later, she called the police to confess what she had done. Conant was charged with child endangerment causing the substantial risk of bodily injury and a prohibited act involving a prescription drug violation, reported Law&Crime on November 5, 2026. An American baby is dead. His mother is in jail. The pills that set this sequence in motion came through a Canadian organization that accepted her word about how far along she was. They continue to ship pills, uninterrupted. Photo of Margaret Conant: Linn County Jail

BREAKING: Budget 2026 leaves pro-life pregnancy centres untouched - Press Release OTTAWA – In the wake of pressure from life-affirming groups, Campaign Life Coalition (CLC) is happy to see the federal government’s decision not to follow the recommendation of Canada’s abortion lobby to penalize pro-life pregnancy care centres in Budget 2026 (“Masters of Our Destiny”), tabled this afternoon. Budget Recommendation 65, submitted by the Abortion Rights Coalition of Canada and adopted by the House of Commons Finance Committee in its September 22 report, called for amendments to the Income Tax Act requiring greater transparency from so-called “anti-abortion pregnancy centres” in order to “mitigate harm to clients and prevent the misuse of charitable status.” “We thank God,” said CLC’s National President Jeff Gunnarson. “This is welcome news for the thousands of women and families who rely on pregnancy care centres across Canada.” Gunnarson said that Recommendation 65 was never about genuine transparency. “It was an ideologically motivated attempt to single out and burden pro-life charities simply because they offer women real alternatives to abortion—including material support, parenting resources, and adoption connections. We are pleased the government has chosen not to advance it.” Pregnancy care centres provide practical, non-coercive help to pregnant women in crisis. Last year alone, centres affiliated with Pregnancy Care Canada reported more than 54,000 client visits, including material assistance such as diapers, formula, and clothing for nearly 9,000 clients. These centres operate under established standards of care and disclose the scope of their services. Pete Baklinski, CLC’s Communications Director, pointed out that the recommendation did not treat pro-life pregnancy care centres as the community-building and life-affirming charities serving vulnerable women that they are, but as a problem to be regulated. “Recommendation 65 was simply slanderous and based on provable lies spread by the abortion lobby. Harm was simply assumed and misuse was treated as a given—with no finding of fact and no hearing.” “Campaign Life Coalition calls on future finance committees to reject recommendations from the abortion lobby intended to harm genuine charities that provide Canadian mothers and fathers the support they need,” Baklinski added.